0054-0092 : Galantamine 12 mg Oral Tablet


NDC0054-0092
Labeler: West-ward Pharmaceuticals Corp.
Product Type: Human Prescription Drug
Drug Name:  Galantamine
Dosage Form: Oral Tablet
Application #: ANDA077608
Rev. Date: 

NDC 0054-0092 QR Code


Appearance:


Markings: 54;421
Shapes:  Round
Colors:  Green
Size (mm): 8
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0054-0092-21: 60 TABLET IN 1 BOTTLE (0054‑0092‑21)

Active Ingredients:

  • Galantamine Hydrobromide

Dosage Strength:

  • 12 mg

Inactive Ingredients:

  • Cellulose, Microcrystalline
  • Anhydrous Lactose
  • Crospovidone (15 Mpa.s At 5%)
  • Silicon Dioxide
  • Magnesium Stearate
  • Titanium Dioxide
  • Polydextrose
  • Hypromellose 2910 (6 Mpa.s)
  • Triacetin
  • Polyethylene Glycol 8000
  • Fd&c Blue No. 1
  • D&c Yellow No. 10
  • Fd&c Red No. 40

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0054-0090 Galantamine 4 mg Oral Tablet by West-ward Pharmaceuticals Corp.
  • 0054-0091 Galantamine 8 mg Oral Tablet by West-ward Pharmaceuticals Corp.
  • 0378-2721 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-2722 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0378-2723 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Mylan Pharmaceuticals Inc.
  • 0555-0138 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Barr Laboratories Inc.
  • 0555-0139 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Barr Laboratories Inc.
  • 0555-0140 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Barr Laboratories Inc.
  • 0615-7541 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-7542 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 0615-7543 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Ncs Healthcare of Ky, Inc Dba Vangard Labs
  • 51079-852 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Mylan Institutional Inc.
  • 51079-853 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Mylan Institutional Inc.
  • 51079-854 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Mylan Institutional Inc.
  • 57237-049 Galantamine 4 mg/1 Oral Tablet, Film Coated by Citron Pharma LLC
  • 57237-050 Galantamine 8 mg/1 Oral Tablet, Film Coated by Citron Pharma LLC
  • 57237-051 Galantamine 12 mg/1 Oral Tablet, Film Coated by Citron Pharma LLC
  • 57315-108 Galantamine 4 mg (As Galantamine Hydrobromide 5.126 mg) Oral Tablet by Alphapharm Pty Ltd
  • 57315-109 Galantamine 8 mg (As Galantamine Hydrobromide 10.253 mg) Oral Tablet by Alphapharm Pty Ltd
  • 57315-110 Galantamine 12 mg (As Galantamine Hydrobromide 15.379 mg) Oral Tablet by Alphapharm Pty Ltd
  • More related products ...
< Prev: 0054-0091Next: 0054-0097 >




Notice: The MedsChat® NDC Database compiles publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.


Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 August 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA